The absolute risk for thyroid cancer is low among patients receiving GLP-1 RA therapy, but risk is elevated in the first year of treatment.

We are a nation of phone lovers but there have been worries in the past that our devices could actually be harming us ...

Madison LeCroy knows the importance of a healthy work-life balance.

Glucagon-like peptide 1 receptor agonist use is not associated with an increased risk for thyroid cancer over the short term.

Thyroid cancer is a disease in which malignant (cancer) cells form in the tissues of the thyroid gland. In 2020, there were ...

On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...

From the reveal of NBA star Dwyane Wade’s cancer surgery to a Bachelorette star on her husband’s cancer diagnosis, here is ...

Thyroid disease is often missed in older adults because its symptoms overlap with those of “normal aging.” In this ...

This post was updated Jan. 31 at 12:28 a.m. Dr. Stephanie Smooke Praw, the interim clinical chief of UCLA Health’s Division ...

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.